WHICH INDICATION FOR BREAST MRI?

Similar documents
Armed Forces Institute of Pathology.

BREAST MRI. VASILIKI FILIPPI RADIOLOGIST CT MRI & PET/CT Departments Hygeia Hospital, Athens, Greece

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

MRI in breast cancer: diagnosis and intervention. Dr Sue Barter Addenbrookes Hospital, Cambridge UK

MR sin plass i brystkreftdiagnostikk, dagens anbefalinger og fremtidsperspektiver

BI-RADS and Breast MRI. Kathy Borovicka, M.D. Thursday February 15, 2018

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD

Breast MRI Update. Jeffrey C. Weinreb, MD, FACR Yale University School of Medicine

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Contrast-enhanced Breast MRI RSSA 2013

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

ROLE OF MRI IN SCREENING, DIAGNOSIS AND MANAGEMENT OF BREAST CANCER. B.Zandi Professor of Radiology

BREAST IMAGING and NEW IMAGING MODALITIES- A Surgeons view

Standard Breast Imaging Modalities. Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine

Breast MRI: Friend or Foe?

Ana Sofia Preto 19/06/2013

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Presented by: Lillian Erdahl, MD

Breast Cancer. Saima Saeed MD

Breast Imaging Update: Old Dog New Tricks

Breast Magnetic Resonance Imaging (MRI) Westmead Breast Cancer Institute

Breast Cancer Imaging

Breast Imaging! Ravi Adhikary, MD!

COPE Library Sample

Breast cancer tumor size: Correlation between MRI and histopathology

How to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer

Can magnetic resonance imaging obviate the need for biopsy for microcalcifications?

Clinical Practice Guideline for the Indications for Use of Breast Magnetic Resonance Imaging (MRI)

Throughout this policy, bracketed numbers link topics across multiple sections according to the indication numbers in the following list.

Breast Cancer Diagnosis, Treatment and Follow-up

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008

MP Magnetic Resonance Imaging for Detection and Diagnosis of Breast Cancer

Successful Breast MRI Program : The ingredients

Breast Imaging Lexicon

New Imaging Modalities for better Screening and Diagnosis

Criteria of Malignancy. Evaluation Score

BREAST PATHOLOGY. Fibrocystic Changes

National Diagnostic Imaging Symposium 2013 SAM - Breast MRI 1

Here are examples of bilateral analog mammograms from the same patient including CC and MLO projections.

MEDICAL IMAGING AND BREAST DISEASE HOW CAN WE HELP YOU?

Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography

Breast pathology. 2nd Department of Pathology Semmelweis University

Screening Mammograms: Questions and Answers

Diseases of the breast (1 of 2)

Leonard M. Glassman MD

STEREOTACTIC BREAST BIOPSY: CORRELATION WITH HISTOLOGY

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Breast MRI: Friend or Foe?

Newly Diagnosed Breast Cancer: Preoperative Imaging and Localization

Breast Cancer. What is breast cancer?

Evaluation of BI-RADS 3 lesions in women with a high risk of hereditary breast cancer.

Mammography. What is Mammography? What are some common uses of the procedure?

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Ductal carcinoma in situ: ultrasound, mammography and MRI features with pathologic correlation

Breast Cancer Screening

DISORDERS OF THE BREAST Dated. FIBROADENOSIS Other common names: mastitis, fibrocystic disease, cystic mammary dysplasia.

ASPS Recommended Insurance Coverage Criteria for Third- Party Payers

MRI features of Triple-negative breast cancer: our experience.

Mammo-50 Eligibility Queries

When do you need PET/CT or MRI in early breast cancer?

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

MANAGEMENT OF DENSE BREASTS. Nichole K Ingalls, MD, MPH NW Surgical Specialists September 25, 2015

Basement membrane in lobule.

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

BI-RADS Update. Martha B. Mainiero, MD, FACR, FSBI Brown University Rhode Island Hospital

Contrast-Enhanced Digital Mammography

Index. C Calcifications fat necrosis 1, 61 fat necrosis 4, 69 nipple/peri-areolar involvement 1, 165

Breast calcification: Management and Pictorial Review

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

RADIOLOGIC EVALUATION OF BREAST CANCER

Diagnostic Dilemmas of Breast Imaging

Contrast Enhanced Spectral Mammography (CESM) Initial UK Experience. Dr Sarah L Tennant BMedSci, BMBS, MRCP, FRCR

Breast Pathology. Breast Development

High Risk Screening: A Multimodality Approach

Melissa Hartman, DO Women s Health Orlando VA Medical Center

Breast Surgery: Yesterday, Today and Tomorrow

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Breast Health. Knowledge and self-awareness are powerful tools. Understanding and utilizing these tools starts with

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Mammography. What is Mammography?

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

Diseases of the breast (2 of 2) Breast cancer

MEDICAL POLICY SUBJECT: MAGNETIC RESONANCE IMAGING (MRI) OF THE BREAST. POLICY NUMBER: CATEGORY: Technology Assessment

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

Imaging the Symptomatic Patient. Avice M.O Connell MD,FACR,FSBI Professor of Imaging Sciences Director, Women s Imaging University of Rochester

1. Screening, Diagnosis and Surgical Management of Breast Cancer

Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks

Triple Negative Breast Cancer

S. Murgo, MD. Chr St-Joseph, Mons Erasme Hospital, Brussels

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

Surgery for Breast Cancer

Transcription:

WHICH INDICATION FOR BREAST MRI? Dr. P. De Visschere, Prof. Dr. G. Villeirs Genitourinary Radiology and Mammography University Hospital Gent Symposium Belgian Menopause Society 13/03/2010

Which Indication For Breast MRI? Breast MRI Contra-Indications No Indications Indications

Breast MRI Bilateral breast coil Prone position Contrast bolus injection (Gadolinium IV)

T Two Water White Breast MRI T1 T2 T1 + Gd sub Cor T1 fs +Gd

Breast MRI Lesion Evaluation Morphologic evaluation Lesion size, contour, internal architecture, Dynamic contrast enhancement evaluation Intralesional enhancement kinetics centripetal vs centrifugal Kwantification of enhancement, time-intensity curves multiple T1 fs GE runs (images every 80 sec) over 5-8 min

Morphologic evaluation Lesion size, contour, internal architecture Round/Oval, homogeneous, regular contour benign Heterogeneous segmental or spicular contour malignant

Dynamic Contrast Enhancement Evaluation Principles of enhancement Invasive lesion Angiogenetic factors Growth of existing capillaries De novo angiogenesis Abnormal configuration: AV- shunts and defective endothelium Enhancement Increased in- and efflux Increased extracellular space Increased extravasation 180 160 140 120 100 80 60 40 20 0 1 2 3 4 5 6

Dynamic Contrast Enhancement Evaluation Signal intensity 120 Time-intensity curves 100 80 60 40 Carcinoom Fibroadenoom Hyperplasie Normaal klierweefsel Spier 20 0 0 1 2 3 4 5 Time (minutes)

Dynamic criteria Time-intensity curves 160 140 120 100 80 60 40 Type 1 curve Linear curve, continued enhancement Usually benign 20 0 0 1 2 3 4 5 6 Type 1

Dynamic criteria Time-intensity curves 160 140 120 100 80 60 40 20 0 0 1 2 3 4 5 6 Type 2 Type 2 curve Plateau curve 4-6 = peak 1-3 (maximum variation of plateau in delayed part of slope: : 10%) Benign and malignant

Dynamic criteria Time-intensity curves 160 140 120 100 80 60 Type 3 curve Wash-out curve Usually malignant 40 20 0 0 1 2 3 4 5 6 Type 3

Accurracy Breast MRI Very high sensitivity (83-100%) in the detection of invasive breast cancer Modest specificity (29-100%) Very high negative predictive value (>98%) for invasive carcinoma

Accurracy Breast MRI False Positives Angiogenetic activity is not exclusive for malignancy Lesion with high vascularisation: overlap between benign and malignant E.g.: Fibroadenoma time-intensity curves:» 83% linear curve» 12% plateau curve» 5% wash-out curve

Accurracy Breast MRI False Positives MRI of dense breast: high background enhancement Diffuse or focal enhancing zones, without mass-effect Usually linear curve (type 1 curve), infrequently plateaucurve Histology: benign hyperplastic disease, adenosis, epitheliosis, Endogeneous or exogeneous hormones cause (focal) hyperemia Premenopausal patient: image between day 5 and 12 of menstrual cycle Postmenopausal patient: discontinue substitution 6 weeks before MRI 180 160 140 120 100 80 60 40 20 0 1 2 3 4 5 6

Accurracy Breast MRI False Negatives Lesion with poor enhancement pattern Invasive malignancy very unlikely: Well differentiated invasive breast cancer Invasive lobular carcinoma DCIS In 16-40% false negative Many cases of DCIS show slow initial enhancement and no washout

Accurracy Breast MRI False Negatives Invasive Lobular Carcinoma Diffuse infiltration of surrounding tissue ( Indian file configuration) Nutrition via existing capillaries or cellular diffusion

Accurracy Breast MRI False Negatives DCIS Tumor inside duct or lobule (intact basal membrane) Nutrition via ductolobular system DCIS

BUBO: Breast Unidentified Bright Object Enhancement of a node <5mm Too small to characterize normal background enhancement Usually stable on follow-up examinations Risk of malignancy extremely low

Contra-indications (Breast)-MRI

Contra-Indication (Breast)-MRI: Ferromagnetic structures Pacemaker, neurostimulator, hearing device, dental prosthesis, metallic splinter in the eye, http://www.mrisafety.com/list_search.asp

Contra-Indication (Breast)-MRI: Claustrophobia Noise 60-90dB 20 minutes

Contra-Indication (Breast)-MRI: Chronic Renal Failure Severe Chronic Renal Failure Gadolinium nephrogenic systemic fibrosis Glomerular filtration rate (GFR) <30 ml/min Cockroft Gault GFR calculator: http://www.nephron.com/cgi-bin/cgsi.cgi

Contra-Indication (Breast)-MRI: Pregnancy First 3 months pregnancy: avoid MRI

No Indication for Breast-MRI

No Indication for Breast MRI: Microcalcifications Microcalcifications on mammography No enhancement on MRI: False negative in DCIS (NPV <85%) Enhancement on MRI False positive in benign hyperplastic disease MRI Biopsy!

No Indication for Breast MRI: Screening low-risk patients Screening low-risk patient with dense breasts MRI MX + US

No Indication for Breast MRI: Alternative for Biopsy Evaluation suspicious lesion on MX/US MRI Biopsy!

Indications Breast-MRI

Indications Breast-MRI Indications limited due to modest specificity When in doubt first discuss indication with the radiologist Screening high-risk patients Preoperative evaluation Detection recurrence after surgery Evaluation neo-adjuvant chemotherapy Evaluation breast implants Axillar adenopathy or metastasis with normal MX and US (discrepancy MX US)

Indications Breast MRI Screening High Risk Patients

Indications Breast-MRI: Screening High Risk Patients High risk patients <40y: MR/y >40y with dense breasts: MR/y (evt also MX+US/y) Advantages Breast-MRI: Highest sensitivity No radiation

Indications Breast-MRI: Screening High Risk Patients EVA Trial, J of Oncology Report, 22 feb 2010 (C. Kuhl): In women at elevated familial risk (>20%), MRI screening shifts the distribution of screen-detected breast cancers to the preinvasive stage. Neither annual MX nor annual/half-yearly US add to the cancer yield achieved by MRI alone.

Indications Breast MRI Preoperative Evaluation

Indications Breast-MRI: Preoperative Evaluation After diagnosis unifocal mammacarcinoma Multifocality? Multicentricity? Contralateral breast? (synchronous ca in 5-20%) Chest wall involvement?

Indications Breast-MRI: Preoperative Evaluation MRI highest accurracy for evaluation lesion size and extension MRI changes treatment in 10-20% Tumorectomy to more extensive surgery or mastectomy

Indications Breast-MRI: Preoperative Evaluation Modest specificity of MRI: Only 20% of additional foci are malignant False positives extra biopsy Sometimes only possible with MRguidance Extra time, costs, patient anxiety,

Indications Breast-MRI: Preoperative Evaluation Importance of these synchronous detected lesions is still unclear: Can they be treated successfully with radiotherapy or chemotherapy? Without treatment will they evolve to lifethreatening tumors?

Indications Breast-MRI: Preoperative Evaluation Indications preoperative MRI controversial MRI in every new diagnosis of mammacarcinoma? MRI only in new diagnosis of mammacarcinoma in mammographic dense breasts? No MRI staging?

Indications Breast-MRI: Preoperative Evaluation COMICE-trial (L. Turnbull, The Lancet, february 2010) 1600 patients, all MX, US and biopsy; 800 in addition also preoperative MR MR group in 16% more extensive surgery No significance difference in reoperation rate after 6 months (18 % vs 19%) : Conclusion preop MR not usefull

Indications Breast MRI Detection Recurrence After Surgery

Indications Breast-MRI: Detection Recurrence After Surgery Recurrence rate 1%/year after surgery Scar tissue or recurrence? Enhancement 2 years after completion of treatment is suspicious wait (3) 6 months after surgery wait (12)-18 months after radiation therapy

Scar tissue Recent scar (< 12-18m): hypervascular inflammation with strong enhancement Old scar (> 18 m): fibrous hypovascular tissue with few/no enhancement

Indications Breast MRI Evaluation Neo-adjuvant Chemotherapy

Indications Breast-MRI: Evaluation Neoadjuvant Chemotherapy MRI highest accurracy for monitoring chemotherapy Change in (residual) tumor size, signal intensity and contrast kinetics Underestimation possible!

Monitoring chemotherapy Underestimation possible!

Indications Breast MRI Evaluation Breast Implants

Indications Breast-MRI: Evaluation Breast Implants Prosthesis complications Rupture of the capsula, fibrosis, dislocation, Silicone implants: MRI is first-line investigation sensitivity MRI 80%, US 60%, MX 40% Detection of tumor recurrence Interpretation MX and US difficult after reconstruction

Prepectoral / Retropectoral Breast Implants

Linguine sign

Indications Breast MRI Axillar adenopathy or metastasis with normal MX and US

Indications Breast-MRI: Axillar adenopathy or metastasis with normal MX or US Detection of primary tumor < 2% of all breast cancers are found via metastatic axillar lymph nodes MX, US and clinically no tumor detectable Sensitivity of MRI in these cases: 75-85%

Indications Breast MRI (Discrepancy MX US)

Indications Breast-MRI: (Discrepancy MX US) Discrepancy clinical findings MX US E.g. bloody nipple discharge, First consider biopsy, retrospective evaluation, MRI high sensitivity, modest specificity: False positives

Take home messages

Take home messages Accurracy Breast MRI for IDCA: Very high sensitivity Modest specificity Very high negative predictive value

Take home messages Contra-indications for (Breast)-MRI Ferromagnetic structures Claustrophobia Severe chronic renal failure Pregnancy <3 months

Take home messages No Indications for Breast MRI Microcalcifications Screening low-risk patients Replacement of biopsy

Take home messages Indications Breast-MRI Screening high-risk patients Preoperative evaluation Detection recurrence after surgery Evaluation neo-adjuvant chemotherapy Evaluation breast implants Axillar adenopathy or metastasis with normal MX and US (Discrepancy MX US)

Take home messages When in doubt first discuss indication with the radiologist Provide thorough clinical information and previous imaging studies (MR/MX/US)